Long intergenic non-protein coding RNA 1579 (LINC01579)

Long intergenic non-protein coding RNA 1579 (LINC01579) is a long non-coding RNA (lncRNA) classified as a long intergenic non-coding RNA (lincRNA), meaning it is longer than 200 nucleotides and does not encode a protein nor overlap with protein-coding genes[3][5][7]. LINC01579 is found to be upregulated in glioblastoma, where it promotes cell proliferation and inhibits apoptosis by acting as a competing endogenous RNA (ceRNA), specifically sponging miR-139-5p, which subsequently regulates the expression of EIF4G2[1][2]. It is also identified as a prognostic biomarker in several cancers, including glioblastoma and gastric cancer, but is not itself a receptor, enzyme, or other standard drug target class[1][2][6][8]. No drugs directly interact with LINC01579, and therapeutic interventions targeting this lncRNA have not been reported in the literature as of the current knowledge cut-off[1][2][6][8].

Not drug-targeted; endogenously functions by: - Sponging miR-139-5p, thus regulating Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) expression[1][2].